Abstract
Background: Administration of dehydroepiandrosterone (DHEA) has been demonstrated to improve survival and cellular immune functions during systemic inflammation. Although there is evidence that the route of drug application may profoundly affect the DHEA-induced effects the impact of this parameter remains to be established. Materials and Methods: Male NMRI mice were subjected to sham-operation (laparotomy) or sepsis (cecal ligation and puncture). Animals received saline or DHEA (20 mg/kg/day) given either subcutaneously, intravenously, or intraperitoneally. Termination of animals was performed 48 hrs after induction of sepsis in order to monitor splenocyte proliferation (3H-thymidine incorporation assay), splenocyte apoptosis (Annexin V binding capacity), and cytokine release (IL-1β and IL-6, ELISA). Results: Subcutaneous DHEA administration improved the survival rate of septic mice 48 hrs after induction of CLP (75% vs. 47%). This effect was paralleled by a restoration of splenocyte proliferation, a decreased cellular apoptosis rate of splenocytes, and an attenuation of pro-inflammatory cytokine release. In contrast, no significant effects on the survival rate or cellular immune functions were observed following intravenous or intraperitoneal DHEA administration. Conclusions: Subcutaneous administration of DHEA induced an increased survival rate and improved cellular immune functions in septic mice. In contrast, no comparable effects were noticed following intravenous or intraperitoneal administration of DHEA.
Keywords: DHEA, drug administration, immune system, mouse, sepsis, survival, Dehydroepiandrosterone, systemic inflammation, laparotomy, 3H-thymidine incorporation assay, splenocyte apoptosis, Annexin V binding capacity, cytokine release, IL-1, IL-6, ELISA, apoptosis, cecal ligation and puncture, Polymicrobial Sepsis Model, ice-cooled RPMI Medium, 96-well microtiter plate, FITC-conjugated recombinant An-nexin V, flow cytome-try, Kaplan-Meier and Cox regression test, Splenocye proliferation, LAP DHEA, CLP DHEA, sham-operated groups, murine models of sepsis
Medicinal Chemistry
Title: Dehydroepiandrosterone Modulates Survival and Immune Functions During Sepsis Depending on the Way of Drug Administration
Volume: 6 Issue: 4
Author(s): Daniel Schmitz, Philipp Kobbe, Alexander Wegner, Florian Hammes and Reiner Oberbeck
Affiliation:
Keywords: DHEA, drug administration, immune system, mouse, sepsis, survival, Dehydroepiandrosterone, systemic inflammation, laparotomy, 3H-thymidine incorporation assay, splenocyte apoptosis, Annexin V binding capacity, cytokine release, IL-1, IL-6, ELISA, apoptosis, cecal ligation and puncture, Polymicrobial Sepsis Model, ice-cooled RPMI Medium, 96-well microtiter plate, FITC-conjugated recombinant An-nexin V, flow cytome-try, Kaplan-Meier and Cox regression test, Splenocye proliferation, LAP DHEA, CLP DHEA, sham-operated groups, murine models of sepsis
Abstract: Background: Administration of dehydroepiandrosterone (DHEA) has been demonstrated to improve survival and cellular immune functions during systemic inflammation. Although there is evidence that the route of drug application may profoundly affect the DHEA-induced effects the impact of this parameter remains to be established. Materials and Methods: Male NMRI mice were subjected to sham-operation (laparotomy) or sepsis (cecal ligation and puncture). Animals received saline or DHEA (20 mg/kg/day) given either subcutaneously, intravenously, or intraperitoneally. Termination of animals was performed 48 hrs after induction of sepsis in order to monitor splenocyte proliferation (3H-thymidine incorporation assay), splenocyte apoptosis (Annexin V binding capacity), and cytokine release (IL-1β and IL-6, ELISA). Results: Subcutaneous DHEA administration improved the survival rate of septic mice 48 hrs after induction of CLP (75% vs. 47%). This effect was paralleled by a restoration of splenocyte proliferation, a decreased cellular apoptosis rate of splenocytes, and an attenuation of pro-inflammatory cytokine release. In contrast, no significant effects on the survival rate or cellular immune functions were observed following intravenous or intraperitoneal DHEA administration. Conclusions: Subcutaneous administration of DHEA induced an increased survival rate and improved cellular immune functions in septic mice. In contrast, no comparable effects were noticed following intravenous or intraperitoneal administration of DHEA.
Export Options
About this article
Cite this article as:
Schmitz Daniel, Kobbe Philipp, Wegner Alexander, Hammes Florian and Oberbeck Reiner, Dehydroepiandrosterone Modulates Survival and Immune Functions During Sepsis Depending on the Way of Drug Administration, Medicinal Chemistry 2010; 6 (4) . https://dx.doi.org/10.2174/1573406411006040229
DOI https://dx.doi.org/10.2174/1573406411006040229 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in Chemical Genomics
Current Medicinal Chemistry HumDLoc: Human Protein Subcellular Localization Prediction Using Deep Neural Network
Current Genomics Epidemiological Evidence Associating Secondhand Smoke Exposure with Cardiovascular Disease
Inflammation & Allergy - Drug Targets (Discontinued) Future Perspectives on the Fibrinolytic Therapy of Intracerebral Hemorrhages
Central Nervous System Agents in Medicinal Chemistry Protective Effect of Resveratrol against Glioblastoma: A Review
Anti-Cancer Agents in Medicinal Chemistry Foreword: The Year in Review: Comments on Plants, Cyclodextrins, Microbiota, and Diabetes
Current Pharmaceutical Design Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors
Current Cancer Drug Targets Hyaluronidase Inhibitors: A Biological and Therapeutic Perspective
Current Medicinal Chemistry Synthesis of Anthraquinone-Ibuprofen Prodrugs with Hydroxyapatite Affinity and Anti-Inflammatory Activity Characteristics
Medicinal Chemistry The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Synthesis, Hydrolysis Kinetics and Pharmacological Evaluation of Aceclofenac Prodrugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Possible Human Endogenous Cryogens
Current Protein & Peptide Science Nanotechnology for Nanomedicine and Delivery of Drugs
Current Pharmaceutical Design C-reactive Protein, Infection, and Outcome After Acute Ischemic Stroke: A Registry and Systematic Review
Current Neurovascular Research Impact of N-acetylcysteine and Etodolac Treatment on Systolic and Diastolic Function in a Rat Model of Myocardial Steatosis Induced by High-Fat-Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets A Focus on Heme Oxygenase-1 (HO-1) Inhibitors
Current Medicinal Chemistry Peptides As Therapeutics with Enhanced Bioactivity
Current Medicinal Chemistry Dendritoma Vaccine for Cancer: A Hopeful Approach
Current Cancer Therapy Reviews Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia
Current HIV Research Recent Advances in Intraocular Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation